B37.6 Candidal endocarditis

Name of the Condition

• Candidal Endocarditis (ICD Code: B37.6)
• Technical term: Candidal endocarditis
• ICD-10 Code: B37.6

Summary

Candidal endocarditis is a fungal infection of the heart's inner lining (endocardium) or heart valves, caused by Candida species. It typically arises from the hematogenous spread of Candida, often in individuals with preexisting heart conditions or compromised immune systems. The condition can lead to valve damage, embolic events, or systemic infection, requiring prompt medical intervention.

Causes

Candidal endocarditis occurs when Candida fungi enter the bloodstream and adhere to damaged heart tissue or prosthetic valves. Common triggers include invasive procedures, intravenous catheter use, or systemic candidiasis. The infection may also develop secondary to other infections or immunosuppressive states.

Risk Factors

• Weakened immune system (e.g., HIV/AIDS, chemotherapy, organ transplantation).
• Prosthetic heart valves or congenital heart defects.
• Intravenous drug use.
• Prolonged use of broad-spectrum antibiotics or corticosteroids.
• Central venous catheters or other indwelling devices.
• Recent cardiac surgery or valve replacement.

Symptoms

• Persistent fever, often with chills.
• New or changing heart murmurs.
• Fatigue or unexplained weight loss.
• Shortness of breath or chest pain.
• Embolic phenomena (e.g., skin lesions, neurological symptoms).
• Signs of heart failure (e.g., edema, dyspnea).

Diagnosis

Diagnosis involves a combination of clinical evaluation, blood cultures, and imaging. Echocardiography (transthoracic or transesophageal) is used to detect vegetations on heart valves. Blood cultures may identify Candida species, and histopathological examination of excised tissue can confirm the diagnosis. Additional tests may assess valve function or systemic involvement.

Treatment Options

Treatment typically includes long-term antifungal therapy (e.g., echinocandins, amphotericin B) and often surgical intervention to repair or replace damaged valves. The choice of medication and duration depends on the infection's severity, valve involvement, and patient-specific factors. Adjunctive therapies may address complications like heart failure.

Prognosis and Follow-Up

Prognosis varies based on the infection's extent, valve damage, and patient comorbidities. Early diagnosis and treatment improve outcomes, but mortality remains significant, especially in immunocompromised individuals. Follow-up includes regular echocardiograms to monitor valve function and repeated blood cultures to ensure eradication of the infection.

Complications

• Heart valve damage or failure.
• Embolic events (e.g., stroke, organ infarction).
• Sepsis or systemic fungal infection.
• Recurrent infection, particularly in prosthetic valve cases.
• Chronic heart failure due to valve dysfunction.

Lifestyle & Prevention

• Maintain good oral and overall hygiene to reduce Candida overgrowth.
• Manage underlying conditions (e.g., diabetes, immune disorders) with medical guidance.
• Avoid unnecessary invasive procedures when possible.
• Promptly address infections or catheter-related issues.
• Follow healthcare provider recommendations for post-surgical care.

When to Seek Professional Help

Seek immediate medical attention if you experience persistent fever, unexplained fatigue, new heart murmurs, or signs of embolic events (e.g., sudden neurological changes, skin lesions). Individuals with prosthetic valves or immunosuppression should report any concerning symptoms promptly.

Tips for Medical Coders

Document the presence of prosthetic valves, valve damage, or embolic events, as these may impact coding specificity. Note the source of infection (e.g., catheter-related, systemic spread) and any surgical interventions. Ensure documentation supports the diagnosis and aligns with clinical findings to justify code assignment.